首页> 美国卫生研究院文献>Molecules >Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery
【2h】

Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery

机译:静电自组装壳聚糖-果胶纳米和微粒的胰岛素输送。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A polyelectrolyte complex system of chitosan-pectin nano- and microparticles was developed to encapsulate the hormone insulin. The aim of this work was to obtain small particles for oral insulin delivery without chemical crosslinkers based on natural and biodegradable polysaccharides. The nano- and microparticles were developed using chitosans (with different degrees of acetylation: 15.0% and 28.8%) and pectin solutions at various charge ratios (n+ given by the chitosan/pectin mass ratio) and total charge. Nano- and microparticles were characterized regarding particle size, zeta potential, production yield, encapsulation efficiency, stability in different media, transmission electron microscopy and cytotoxicity assays using Caco-2 cells. The insulin release was evaluated in vitro in simulated gastric and intestinal media. Small-sized particles (~240–~1900 nm) with a maximum production yield of ~34.0% were obtained. The highest encapsulation efficiency (~62.0%) of the system was observed at a charge ratio (n+) 5.00. The system was stable in various media, particularly in simulated gastric fluid (pH 1.2). Transmission electron microscopy (TEM) analysis showed spherical shape particles when insulin was added to the system. In simulated intestinal fluid (pH 6.8), controlled insulin release occurred over 2 h. In vitro tests indicated that the proposed system presents potential as a drug delivery for oral administration of bioactive peptides.
机译:开发了壳聚糖-果胶纳米和微粒的聚电解质复合物系统,以封装激素胰岛素。这项工作的目的是获得基于天然和可生物降解多糖的,无需化学交联剂的口服胰岛素小颗粒。使用壳聚糖(乙酰化程度分别为15.0%和28.8%)和果胶溶液以各种电荷比(n + / n -给定)开发纳米和微粒。通过壳聚糖/果胶质量比)和总电荷。使用Caco-2细胞对纳米和微粒进行了表征,涉及粒径,ζ电势,产量,包封效率,在不同培养基中的稳定性,透射电子显微镜和细胞毒性测定。在模拟的胃和肠介质中体外评估胰岛素释放。获得了最大产率为〜34.0%的小尺寸颗粒(〜240-〜1900 nm)。在电荷比(n + / n -)5.00时,观察到系统的最高封装效率(〜62.0%)。该系统在各种介质中均稳定,尤其是在模拟胃液(pH 1.2)中。当向系统中添加胰岛素时,透射电子显微镜(TEM)分析显示球形颗粒。在模拟肠液(pH 6.8)中,胰岛素的释放在2小时内发生。体外测试表明,拟议的系统具有口服生物活性肽的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号